McKesson Corporation (MCK)
McKesson (MCK) Advances While Market Declines: Some Information for Investors
In the most recent trading session, McKesson (MCK) closed at $834.16, indicating a +1.24% shift from the previous trading day.
McKesson Corporation (MCK) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
McKesson Corporation (MCK) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Why McKesson (MCK) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
McKesson (MCK) Stock Slides as Market Rises: Facts to Know Before You Trade
McKesson (MCK) concluded the recent trading session at $814.63, signifying a -1.13% move from its prior day's close.
Here's Why McKesson (MCK) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Investors Heavily Search McKesson Corporation (MCK): Here is What You Need to Know
McKesson (MCK) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
McKesson Builds Earnings Momentum on Specialty and Automation
McKesson posts a strong fiscal second quarter, lifts full-year EPS outlook, and shows how specialty growth and automation are reshaping its earnings power.
Is It Worth Investing in McKesson (MCK) Based on Wall Street's Bullish Views?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Here is What to Know Beyond Why McKesson Corporation (MCK) is a Trending Stock
Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
McKesson Corporation: FY26 Earnings Visibility Underpins Buy Case
McKesson Corporation is undervalued despite strong revenue growth, margin expansion, and capital returns; I rate it Buy with a $920 target (13.5% upside). MCK's strategy focuses on boosting margins by growing high-margin Oncology & Multispecialty and divesting low-margin Medical-Surgical Solutions. Q2 results confirmed margin expansion: revenue hit a record $103.15B (+10% y/y), EPS beat consensus by 9%, and operating profit rose 26% y/y.
Why McKesson (MCK) is a Top Growth Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
McKesson (MCK) Rises As Market Takes a Dip: Key Facts
McKesson (MCK) reached $823.01 at the closing of the latest trading day, reflecting a +1.13% change compared to its last close.
